These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33022914)

  • 1. Antibiotic Treatment Response in Chronic Lyme Disease: Why Do Some Patients Improve While Others Do Not?
    Johnson L; Shapiro M; Stricker RB; Vendrow J; Haddock J; Needell D
    Healthcare (Basel); 2020 Oct; 8(4):. PubMed ID: 33022914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removing the Mask of Average Treatment Effects in Chronic Lyme Disease Research Using Big Data and Subgroup Analysis.
    Johnson L; Shapiro M; Mankoff J
    Healthcare (Basel); 2018 Oct; 6(4):. PubMed ID: 30322049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Biological Sex Matter in Lyme Disease? The Need for Sex-Disaggregated Data in Persistent Illness.
    Johnson L; Shapiro M; Janicki S; Mankoff J; Stricker RB
    Int J Gen Med; 2023; 16():2557-2571. PubMed ID: 37351009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease.
    Stricker RB
    Clin Infect Dis; 2007 Jul; 45(2):149-57. PubMed ID: 17578772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective value of prophylactic antibiotic treatment of tick bite for Lyme disease prevention: an animal model.
    Piesman J; Hojgaard A
    Ticks Tick Borne Dis; 2012 Jun; 3(3):193-6. PubMed ID: 22421585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional outcomes in patients with Borrelia burgdorferi reinfection.
    Jares TM; Mathiason MA; Kowalski TJ
    Ticks Tick Borne Dis; 2014 Feb; 5(1):58-62. PubMed ID: 24215678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misdiagnosis of Lyme Disease With Unnecessary Antimicrobial Treatment Characterizes Patients Referred to an Academic Infectious Diseases Clinic.
    Kobayashi T; Higgins Y; Samuels R; Moaven A; Sanyal A; Yenokyan G; Lantos PM; Melia MT; Auwaerter PG
    Open Forum Infect Dis; 2019 Jul; 6(7):. PubMed ID: 31363774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.
    Klempner MS; Hu LT; Evans J; Schmid CH; Johnson GM; Trevino RP; Norton D; Levy L; Wall D; McCall J; Kosinski M; Weinstein A
    N Engl J Med; 2001 Jul; 345(2):85-92. PubMed ID: 11450676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody profile to Borrelia burgdorferi in veterinarians from Nuevo León, Mexico, a non-endemic area of this zoonosis.
    Skinner-Taylor CM; Flores MS; Salinas JA; Arevalo-Niño K; Galán-Wong LJ; Maldonado G; Garza-Elizondo MA
    Reumatologia; 2016; 54(3):97-102. PubMed ID: 27504018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyme Disease: Diversity of
    Fesler MC; Shah JS; Middelveen MJ; Du Cruz I; Burrascano JJ; Stricker RB
    Healthcare (Basel); 2020 Apr; 8(2):. PubMed ID: 32295182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area.
    Kowalski TJ; Tata S; Berth W; Mathiason MA; Agger WA
    Clin Infect Dis; 2010 Feb; 50(4):512-20. PubMed ID: 20070237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Serologic Test Panel for Detection of Powassan Virus Infection in U.S. Patients Residing in Regions Where Lyme Disease Is Endemic.
    Thomm AM; Schotthoefer AM; Dupuis AP; Kramer LD; Frost HM; Fritsche TR; Harrington YA; Knox KK; Kehl SC
    mSphere; 2018; 3(1):. PubMed ID: 29359181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Related Differential Stimulation of Immune Response by
    Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
    Front Immunol; 2018; 9():2891. PubMed ID: 30619263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Next-Generation Sequencing-Based Molecular Approach to Characterize a Tick Vector in Lyme Disease.
    Madugundu AK; Muthusamy B; Sreenivasamurthy SK; Bhavani C; Sharma J; Kumar B; Murthy KR; Ravikumar R; Pandey A
    OMICS; 2018 Aug; 22(8):565-574. PubMed ID: 30106352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden.
    Gustafson R; Svenungsson B; Forsgren M; Gardulf A; Granström M
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):894-900. PubMed ID: 1486884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
    Wagner B; Goodman LB; Rollins A; Freer HS
    Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
    Feng J; Shi W; Zhang S; Zhang Y
    Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to lyme disease.
    Auwaerter PG
    Clin Infect Dis; 2007 Jul; 45(2):143-8. PubMed ID: 17578771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyme Disease: What the Wilderness Provider Needs to Know.
    Forrester JD; Vakkalanka JP; Holstege CP; Mead PS
    Wilderness Environ Med; 2015 Dec; 26(4):555-64. PubMed ID: 26141918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
    Shemenski J
    Med Hypotheses; 2019 Jul; 128():94-100. PubMed ID: 27107653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.